Ms. Holmes and Mr. Balwani were found guilty of defrauding investors by falsely claiming Theranos’ technology could conduct fast, accurate blood tests with just a drop of blood. On Feb. 24, the appeals court ruled that their convictions were valid and that any minor legal errors during the 2022 trial did not affect the overall outcome. Becker’s obtained these court documents.
Ms. Holmes’ lawyers presented her appeal in a California federal appeals court June 11.
With their appeals rejected, Ms. Holmes and Mr. Balwani will remain in prison.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
